[Oral antidiabetics].
D000284:Administration, Oral; D001645:Biguanides / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000188:drug therapy*; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D013453:Sulfonylurea Compounds / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use
D001645:Biguanides; D007004:Hypoglycemic Agents; D013453:Sulfonylurea Compounds
Perorale Antidiabetica.